Corrigendum to "Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients"

Affiliations

• ¹ Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
• ² Proteomic Unit, Instituto de Investigaciones Sanitarias-IDIS, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), Santiago de Compostela, Spain.
• ³ CITMAga, University of Santiago de Compostela (Campus Vida), Santiago de Compostela, Spain.
• ⁴ Department of Oncology, University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.
• ⁵ Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; CIBERONC, Centro de Investigación Biomédica en Red Cáncer, Madrid, Spain.
• ⁶ Department of Gynecology, University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain.
• ⁷ Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Department of Oncology, University Hospital of Santiago de Compostela (SERGAS), Santiago de Compostela, Spain; CIBERONC, Centro de Investigación Biomédica en Red Cáncer, Madrid, Spain.
• ⁸ Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; CIBERONC, Centro de Investigación Biomédica en Red Cáncer, Madrid, Spain. Electronic address: clotildecnogueira@gmail.com.